Sign in
8-K

Current Report

Vistagen Therapeutics, Inc. Filed Acc 0001654954-21-005102

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading vtgn8k_05012021.htm…